Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 12062912)

1.

Early changes in prefrontal activity characterize clinical responders to antidepressants.

Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH.

Neuropsychopharmacology. 2002 Jul;27(1):120-31.

2.
3.

Changes in brain function of depressed subjects during treatment with placebo.

Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M.

Am J Psychiatry. 2002 Jan;159(1):122-9.

PMID:
11772700
4.

Prefrontal changes and treatment response prediction in depression.

Cook IA, Leuchter AF.

Semin Clin Neuropsychiatry. 2001 Apr;6(2):113-20.

PMID:
11296311
5.

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.

Bares M, Brunovsky M, Kopecek M, Novak T, Stopkova P, Kozeny J, Sos P, Krajca V, Höschl C.

Eur Psychiatry. 2008 Aug;23(5):350-5. doi: 10.1016/j.eurpsy.2008.03.001. Epub 2008 May 2.

PMID:
18450430
6.

Does prior antidepressant treatment of major depression impact brain function during current treatment?

Hunter AM, Cook IA, Leuchter AF.

Eur Neuropsychopharmacol. 2012 Oct;22(10):711-20. doi: 10.1016/j.euroneuro.2012.02.005. Epub 2012 Mar 23.

PMID:
22445212
7.

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):319-25. Epub 2006 Aug 4.

PMID:
16889798
8.

Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.

Hunter AM, Muthén BO, Cook IA, Leuchter AF.

J Psychiatr Res. 2010 Jan;44(2):90-8. doi: 10.1016/j.jpsychires.2009.06.006. Epub 2009 Jul 24.

9.

Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF.

Psychiatry Res. 2009 Nov 30;174(2):152-7. doi: 10.1016/j.pscychresns.2009.04.011. Epub 2009 Oct 22.

10.

The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.

Bares M, Novak T, Brunovsky M, Kopecek M, Stopkova P, Krajca V, Höschl C.

J Psychiatr Res. 2012 Feb;46(2):219-25. doi: 10.1016/j.jpsychires.2011.09.006. Epub 2011 Sep 21.

PMID:
21937059
11.

Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.

Hunter AM, Leuchter AF, Cook IA, Abrams M.

Acta Psychiatr Scand. 2010 Dec;122(6):461-9. doi: 10.1111/j.1600-0447.2010.01560.x.

PMID:
20384600
12.

Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.

Hunter AM, Ravikumar S, Cook IA, Leuchter AF.

Acta Psychiatr Scand. 2009 Apr;119(4):266-73. doi: 10.1111/j.1600-0447.2008.01305.x. Epub 2008 Dec 9.

PMID:
19077131
13.

Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.

Korb AS, Hunter AM, Cook IA, Leuchter AF.

Psychiatry Res. 2011 Jun 30;192(3):188-94. doi: 10.1016/j.pscychresns.2010.12.007. Epub 2011 May 4.

14.

Changes in brain function during administration of venlafaxine or placebo to normal subjects.

Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B.

Clin EEG Neurosci. 2008 Oct;39(4):175-81.

PMID:
19044214
15.

The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.

Bares M, Brunovsky M, Novak T, Kopecek M, Stopkova P, Sos P, Krajca V, Höschl C.

Eur Neuropsychopharmacol. 2010 Jul;20(7):459-66. doi: 10.1016/j.euroneuro.2010.03.007. Epub 2010 Apr 24.

PMID:
20421161
16.

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.

Korb AS, Hunter AM, Cook IA, Leuchter AF.

Clin Neurophysiol. 2009 Jul;120(7):1313-9. doi: 10.1016/j.clinph.2009.05.008. Epub 2009 Jun 17.

17.

Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?

Hunter AM, Cook IA, Abrams M, Leuchter AF.

Med Hypotheses. 2013 Dec;81(6):1004-11. doi: 10.1016/j.mehy.2013.09.016. Epub 2013 Sep 17.

PMID:
24112999
18.

Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.

Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M.

J Psychiatr Res. 2005 Sep;39(5):461-6.

PMID:
15992554
19.

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ.

Psychiatry Res. 1999 Mar 22;85(3):263-73. Erratum in: Psychiatry Res 2000 Jul 24;95(1):87.

PMID:
10333379
20.

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E.

Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. Epub 2004 Jul 14.

PMID:
15252704
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk